Anzeige
Mehr »
Login
Dienstag, 01.04.2025 Börsentäglich über 12.000 News von 695 internationalen Medien
Kurs-Explosion voraus?: Diese kaum bekannte Aktie bohrt jetzt im Hotspot - und du erfährst es als Erster!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Edison Investment Research-Archiv vom 08.02.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
08.02.24Babcock International Group - Steadfast defence543Babcock's capital markets day reaffirmed its transformation over the past two years, facilitated by a series of disposals and a focus on core defence expertise (69% of H124 revenue). It is well positioned...
► Artikel lesen
08.02.24Creo Medical - Solid FY23 lays the groundwork for 2024354Creo Medical has released a trading update for FY23, an active year for the company, with progress made across all business segments. Traction improved in H223, following Speedboat Inject's European...
► Artikel lesen
08.02.24Nanoco - Steps on the pathway to volume production312Nanoco's trading update confirms that H124 revenues and EBITDA are anticipated to be in line with company expectations. The main new information is that the company has commenced the build and fitout...
► Artikel lesen
08.02.24Intralot Integrated Lottery Systems and Services - In it to win it352Intralot Integrated Lottery Systems and Services (Intralot) is a leading developer and supplier of integrated gaming systems and services that cover the entire value chain of select gaming markets....
► Artikel lesen
08.02.24AFT Pharmaceuticals - US maiden voyage with Maxigesic IV launch285AFT Pharmaceuticals has announced the launch of Maxigesic IV, an intravenous form of its flagship pain relief prescription medicine, in the US market by licensing partner Hikma, under the brand name...
► Artikel lesen
08.02.24VolitionRx - Snaring sepsis, with early NETs detection531VolitionRx continues to make headway in growing a body of clinical evidence to build Nu.Q® NETs as a potential breakthrough tool in sepsis. These efforts, coupled with its CE mark in Europe, are a strong...
► Artikel lesen